DEVICE · Unmapped registry intervention
FlexPen®
Find medicine records ·
Find other trials using this name
Clinical trial
Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe
NCT00127296
Study summary
ClinicalTrials.govReliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DEVICE · Unmapped registry intervention
vial and syringe
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Diabetesverified · MONDO: diabetes mellitus
Delivery Systemsunresolved
Interventions
FlexPen®DEVICE
vial and syringeDEVICE
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00127296 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.